Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence.

Autor: Rudman, Sarah M.1, Gray, Kathryn P.2, Batista, Julie L.3,4, Pitt, Michael J.4, Giovannucci, Edward L.3,4,5,6, Harper, Peter G.1, Loda, Massimo4, Mucci, Lorelei A.3,4, Sweeney, Christopher J.7,8 christopher_sweeney@dfci.harvard.edu
Zdroj: BJU International. Dec2016, Vol. 118 Issue 6, p919-926. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje